-
Smegglutide has been approved for the treatment of obesity in China, with a supply chain gap of over 70 billion US dollars in the market
June 25th. Novo Nordisk announced that the National Medical Products Administration has approved its research and production of Novo Nordisk; reg; The marketing application of Smegglutide Injection f ... -
Seizing the market recovery trend, "American version Tieba" seeks to launch an IPO in March
According to insiders, Reddit, one of the world's most influential social platforms and known as the "American version Tieba," has developed a detailed plan to launch its initial public offering (IPO ...